Delivery Order SPE2DB22D2206-SPE2DB25FHA33
Award Date
5/16/25
Potential Completion Date
5/19/25
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,094.67, is a delivery order for the supply of DURAMORPH 5 MG/10 ML AMPUL 10ML, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,017.00 firm fixed-price delivery order is for the supply of DURAMORPH 10 MG/10 ML AMPUL 10ML, a specialty pharmaceutical product. The contract has an ultimate completion date of November 1, 2024 and was awarded on October 31, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract is for the supply of DURAMORPH 5 MG/10 ML AMPUL 10ML, a pharmaceutical product, with a ceiling value of $2,479.26. The contract has an ultimate completion date of August 14, 2024 and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including to...
This federal contract award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,142.30 firm fixed price delivery order is for the supply of DURAMORPH 5 MG/10 ML AMPUL 10ML, a pharmaceutical product. The contract has a ceiling value of $2,142.30 and an ultimate completion date of December 2, 2024. This award is not associated with a set-aside designation, indicating open...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical and medical supply distributor, for the delivery of DURAMORPH 5 MG/10 ML AMPUL 10ML, a pain medication. The contract, awarded by the Defense Logistics Agency (DLA), is a Firm Fixed Price Delivery Order with a ceiling value of $1,670.53 and an ultimate completion date of October 11, 2024. This contract is not associated with a set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product DURAMORPH 5 MG/10 ML AMPUL 10ML, with a ceiling value of $1,243.59 and a period of performance through March 22, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA with a potential value of up to $999,999,999.00 and a performance...
This federal contract award, identified as SPE2DX15D1053|SPE2DX25F6NMW, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,711.60 firm fixed-price delivery order is for the supply of DURAMORPH 5 MG/10 ML AMPUL 10ML, a pharmaceutical product, with a period of performance through May 14, 2025. The contract is not designated as a set-aside and represents an open competition award....
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,466.40 and is a firm fixed-price, non-set-aside delivery order. It covers the delivery of a variety of pharmaceutical products and medical supplies to support military healthcare programs, including medications across multiple therapeutic domains such as diabetes, neurology, pain...
This federal contract award, valued at $5,296.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and it has an ultimate completion date of August 26, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $2,492.54 and a performance period through May 16, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...